Literature DB >> 642995

Lecithin can suppress tardive dyskinesia.

J H Growdon, A J Gelenberg, J Doller, M J Hirsch, R J Wurtman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 642995

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Use of choline in the treatment of ataxia associated with multiple sclerosis.

Authors:  R A Blattel
Journal:  Can Med Assoc J       Date:  1979-12-22       Impact factor: 8.262

2.  Effect of lecithin on disability and plasma free-choline levels in Friedreich's ataxia.

Authors:  S Chamberlain; N Robinson; J Walker; C Smith; S Benton; C Kennard; M Swash; B Kilkenny; S Bradbury
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-09       Impact factor: 10.154

Review 3.  Management of tardive dyskinesia: current update.

Authors:  G M Simpson; E H Pi; J J Sramek
Journal:  Drugs       Date:  1982-05       Impact factor: 9.546

4.  A cell membrane correlate of tardive dyskinesia in patients treated with phenothiazines.

Authors:  G S Zubenko; B M Cohen
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Effects of cholinergic and anticholinergic drugs on ketamine-induced linguopharyngeal motor activity.

Authors:  L A Marco; R S Joshi; C Brown; L D Aldes; R B Chronister
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

6.  Adverse neurologic effects of metoclopramide.

Authors:  J D Grimes; M N Hassan; D N Preston
Journal:  Can Med Assoc J       Date:  1982-01-01       Impact factor: 8.262
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.